metricas
covid
Medicina Clínica (English Edition) Efgartigimod for the treatment of Guillain–Barré syndrome with concurrent pos...
Journal Information
Vol. 165. Issue 1.
(July 2025)
Share
Download PDF
More article options
Vol. 165. Issue 1.
(July 2025)
Letter to the Editor
Efgartigimod for the treatment of Guillain–Barré syndrome with concurrent posterior reversible encephalopathy syndrome
Efgartigimod para el tratamiento del síndrome de Guillain-Barré con síndrome de encefalopatía posterior reversible concurrente
Weiwei Taoa, Hui Liangb, Weijun Hongc,
Corresponding author
hongwj@enzemed.com

Corresponding author.
a Department of Neurology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang Province, China
b Department of Neurology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
c Department of Neurology, Enze Hospital, Taizhou Enze Medical Center (Group), Taizhou, Zhejiang Province, China
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools